A Multicenter Study to Assess the Effect of Plasma Exchange in Accelerating the Clearance of Natalizumab in Subjects With Multiple Sclerosis (MS)

Clinical trial NCT00424788 · COMPLETED

Trial details

NCT number: NCT00424788
Sponsor: Biogen
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsing Forms of Multiple Sclerosis

Start date: 2007-01-01
Primary completion: 2007-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.